Search
Luis A. Diaz, MD, has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an associate professor of oncology at the Johns Hopkins University School of Medicine. Dr. Diaz formally assumes the role as David Spriggs, MD, steps down after nearly 13 years.
In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new longitudinal study from researchers at Memorial Sloan Kettering Cancer Center finds that while clinicians' and patients' reporting of treatment side effects are very different from each other, together they provide a more complete, clinically meaningful picture of the treatment experience.
For many people with lung cancer, targeted therapies can provide effective, long-term control of their disease with fewer side effects than chemotherapy.
A five-year grant of more than $1.4 million will fund a program to train nurses in helping survivors achieve the best possible quality of life after cancer.
Read about the latest MSK research to make CAR T therapy effective against solid tumors.
A new clinical and research center at Memorial Sloan Kettering is dedicated to improving the care of young people with cancer.
Restrictions due to COVID-19 are leaving many feeling isolated or lonely. MSK Psychologist Kelly Trevino, PhD, shares simple ways to find meaning and stay connected during this time.
With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.
MSK’s Francesca Gany emphasized the need to overcome the digital and linguistic divides between the healthcare system and communities.
Memorial Sloan Kettering has launched a collaborative translational research center that will unite researchers specializing in two rapidly growing fields: molecular imaging and nanotechnology.